ThinkSabio

$DNLI

$19.45▲ +3.1% YTD

5 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History
News
DNLI ▲ +3.1% - Denali Therapeutics Inc.
CP $19.45▲ +3.1%Nov 3, 2026 · ThinkSabio Blog

$DNLI - Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights…

News
DNLI ▼ -0.5% - Denali Therapeutics Inc.
CP $19.25▲ -0.5%Oct 30, 2026 · ThinkSabio Blog

$DNLI - Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product…

News
DNLI ▼ -0.1% - Denali Therapeutics Inc.
CP $18.66▲ -0.1%Oct 22, 2026 · ThinkSabio Blog

$DNLI - Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026…

SEC 13D/G
DNLI SEC Filing Update (04-AUG-2026) | ThinkSabio - Stocks Simplified
$23.50▲ 44.35%Aug 4, 2026 · ThinkSabio Blog

$DNLI SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #DNLI : $23.50 Sector: Healthcare | YTD: 🔼+ 44.35% The SEC discl…

SEC 13D/G
$DNLI SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks Simplified
$25.75▲ 58.17%Jul 8, 2026 · ThinkSabio Blog

$DNLI SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #DNLI : $25.75 Sector: Healthcare | YTD: 🔼+ 58.17% The SEC discl…